Pharma Royalty Interest Deal Toy

Royalty Interest Sale Deal Toy

Crystal deal toy marking the sale of a royalty interest in OXLUMO. OXLUMO has been approved by both the Food and Drug Administration (FDA), and the European Medicine’s Agency (EMA).

(21ALJ215)